[English] 日本語
Yorodumi
- PDB-1hra: THE SOLUTION STRUCTURE OF THE HUMAN RETINOIC ACID RECEPTOR-BETA D... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1hra
TitleTHE SOLUTION STRUCTURE OF THE HUMAN RETINOIC ACID RECEPTOR-BETA DNA-BINDING DOMAIN
ComponentsRETINOIC ACID RECEPTOR
KeywordsDNA-BINDING RECEPTOR
Function / homology
Function and homology information


ventricular cardiac muscle cell differentiation / embryonic eye morphogenesis / glandular epithelial cell development / cellular response to corticotropin-releasing hormone stimulus / growth plate cartilage development / embryonic digestive tract development / nuclear glucocorticoid receptor binding / striatum development / neural precursor cell proliferation / negative regulation of chondrocyte differentiation ...ventricular cardiac muscle cell differentiation / embryonic eye morphogenesis / glandular epithelial cell development / cellular response to corticotropin-releasing hormone stimulus / growth plate cartilage development / embryonic digestive tract development / nuclear glucocorticoid receptor binding / striatum development / neural precursor cell proliferation / negative regulation of chondrocyte differentiation / embryonic hindlimb morphogenesis / regulation of myelination / ureteric bud development / Signaling by Retinoic Acid / heterocyclic compound binding / retinoic acid receptor signaling pathway / nuclear retinoid X receptor binding / negative regulation of stem cell proliferation / hormone-mediated signaling pathway / neurogenesis / stem cell proliferation / multicellular organism growth / Activation of anterior HOX genes in hindbrain development during early embryogenesis / Nuclear Receptor transcription pathway / nuclear receptor activity / sequence-specific double-stranded DNA binding / transcription regulator complex / cell differentiation / DNA-binding transcription factor activity, RNA polymerase II-specific / positive regulation of apoptotic process / RNA polymerase II cis-regulatory region sequence-specific DNA binding / apoptotic process / protein-containing complex binding / chromatin / negative regulation of transcription by RNA polymerase II / signal transduction / positive regulation of transcription by RNA polymerase II / DNA binding / zinc ion binding / nucleoplasm / nucleus / cytoplasm
Similarity search - Function
: / : / Retinoic acid receptor / Erythroid Transcription Factor GATA-1, subunit A / Erythroid Transcription Factor GATA-1; Chain A / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Zinc finger, C4 type (two domains) / Nuclear hormone receptors DNA-binding domain profile. ...: / : / Retinoic acid receptor / Erythroid Transcription Factor GATA-1, subunit A / Erythroid Transcription Factor GATA-1; Chain A / Nuclear hormone receptor / Nuclear hormones receptors DNA-binding region signature. / Zinc finger, nuclear hormone receptor-type / Zinc finger, C4 type (two domains) / Nuclear hormone receptors DNA-binding domain profile. / c4 zinc finger in nuclear hormone receptors / Nuclear hormone receptor, ligand-binding domain / Nuclear hormone receptor-like domain superfamily / Ligand-binding domain of nuclear hormone receptor / Nuclear receptor (NR) ligand-binding (LBD) domain profile. / Ligand binding domain of hormone receptors / Zinc finger, NHR/GATA-type / 2-Layer Sandwich / Alpha Beta
Similarity search - Domain/homology
Retinoic acid receptor beta
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodSOLUTION NMR
AuthorsKnegtel, R.M.A. / Katahira, M. / Schilthuis, J.G. / Bonvin, A.M.J.J. / Boelens, R. / Eib, D. / Van Der Saag, P.T. / Kaptein, R.
Citation
Journal: J.Biomol.NMR / Year: 1993
Title: The solution structure of the human retinoic acid receptor-beta DNA-binding domain.
Authors: Knegtel, R.M. / Katahira, M. / Schilthuis, J.G. / Bonvin, A.M. / Boelens, R. / Eib, D. / van der Saag, P.T. / Kaptein, R.
#1: Journal: Biochem.Biophys.Res.Commun. / Year: 1993
Title: Heteronuclear 113Cd-1H NMR Study of Metal Coordination in the Human Retinoic Acid Receptor-Beta DNA Binding Domain
Authors: Knegtel, R.M.A. / Boelens, R. / Ganadu, M.L. / George, A.V.E. / Van Der Saag, P.T. / Kaptein, R.
#2: Journal: Biochemistry / Year: 1992
Title: Homo-and Heteronuclear NMR Studies of the Human Retinoic Acid Receptor Beta DNA-Binding Domain: Sequential Assignments and Identification of Secondary Structure Elements
Authors: Katahira, M. / Knegtel, R.M.A. / Boelens, R. / Eib, D. / Schilthuis, J.G. / Van Der Saag, P.T. / Kaptein, R.
History
DepositionJul 25, 1993Processing site: BNL
Revision 1.0Jan 31, 1994Provider: repository / Type: Initial release
Revision 1.1Mar 24, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance
Revision 1.3Feb 23, 2022Group: Database references / Derived calculations / Other
Category: database_2 / pdbx_database_status ...database_2 / pdbx_database_status / pdbx_struct_assembly / pdbx_struct_conn_angle / pdbx_struct_oper_list / struct_conn / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.process_site / _pdbx_struct_conn_angle.ptnr1_auth_seq_id / _pdbx_struct_conn_angle.ptnr1_label_seq_id / _pdbx_struct_conn_angle.ptnr3_auth_seq_id / _pdbx_struct_conn_angle.ptnr3_label_seq_id / _pdbx_struct_conn_angle.value / _struct_conn.pdbx_dist_value / _struct_conn.ptnr1_auth_comp_id / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_asym_id / _struct_conn.ptnr1_label_atom_id / _struct_conn.ptnr1_label_comp_id / _struct_conn.ptnr1_label_seq_id / _struct_conn.ptnr2_auth_comp_id / _struct_conn.ptnr2_auth_seq_id / _struct_conn.ptnr2_label_asym_id / _struct_conn.ptnr2_label_atom_id / _struct_conn.ptnr2_label_comp_id / _struct_conn.ptnr2_label_seq_id / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id
Revision 1.4May 22, 2024Group: Data collection / Category: chem_comp_atom / chem_comp_bond

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: RETINOIC ACID RECEPTOR
hetero molecules


Theoretical massNumber of molelcules
Total (without water)9,5653
Polymers9,4341
Non-polymers1312
Water00
1


  • Idetical with deposited unit
  • defined by author
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Atom site foot note1: LYS 6 - PRO 7 MODEL 1 OMEGA =274.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: CYS 8 - PHE 9 MODEL 1 OMEGA = 2.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: CYS 11 - GLN 12 MODEL 1 OMEGA =355.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: SER 15 - SER 16 MODEL 1 OMEGA =128.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: MET 40 - ILE 41 MODEL 1 OMEGA =137.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: HIS 45 - ARG 46 MODEL 1 OMEGA = 96.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: CYS 50 - VAL 51 MODEL 1 OMEGA =212.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: ILE 52 - ASN 53 MODEL 1 OMEGA =143.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: VAL 55 - THR 56 MODEL 1 OMEGA =231.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: ARG 57 - ASN 58 MODEL 1 OMEGA = 6.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: ARG 64 - LEU 65 MODEL 1 OMEGA =144.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: SER 74 - LYS 75 MODEL 1 OMEGA =120.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: LYS 75 - GLU 76 MODEL 1 OMEGA =216.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: VAL 78 - ARG 79 MODEL 1 OMEGA =351.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: LYS 6 - PRO 7 MODEL 2 OMEGA =319.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: PRO 7 - CYS 8 MODEL 2 OMEGA =224.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: CYS 8 - PHE 9 MODEL 2 OMEGA = 1.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: CYS 11 - GLN 12 MODEL 2 OMEGA = 1.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: GLY 17 - TYR 18 MODEL 2 OMEGA = 11.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: GLN 37 - LYS 38 MODEL 2 OMEGA =139.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: LYS 38 - ASN 39 MODEL 2 OMEGA =346.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: MET 40 - ILE 41 MODEL 2 OMEGA =134.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: HIS 45 - ARG 46 MODEL 2 OMEGA = 96.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: ASN 53 - LYS 54 MODEL 2 OMEGA =247.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: VAL 55 - THR 56 MODEL 2 OMEGA =220.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: ARG 57 - ASN 58 MODEL 2 OMEGA = 8.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: ARG 64 - LEU 65 MODEL 2 OMEGA =146.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: SER 74 - LYS 75 MODEL 2 OMEGA =118.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: LYS 75 - GLU 76 MODEL 2 OMEGA =213.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: VAL 78 - ARG 79 MODEL 2 OMEGA = 2.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: ARG 3 - VAL 4 MODEL 3 OMEGA = 3.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: LYS 6 - PRO 7 MODEL 3 OMEGA =319.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: PRO 7 - CYS 8 MODEL 3 OMEGA =223.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: CYS 8 - PHE 9 MODEL 3 OMEGA = 8.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: CYS 11 - GLN 12 MODEL 3 OMEGA =333.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: ASP 13 - LYS 14 MODEL 3 OMEGA =359.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: VAL 22 - SER 23 MODEL 3 OMEGA =140.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: MET 40 - ILE 41 MODEL 3 OMEGA =144.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: CYS 44 - HIS 45 MODEL 3 OMEGA = 10.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: HIS 45 - ARG 46 MODEL 3 OMEGA = 35.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: CYS 50 - VAL 51 MODEL 3 OMEGA =266.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: VAL 51 - ILE 52 MODEL 3 OMEGA =213.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: VAL 55 - THR 56 MODEL 3 OMEGA =211.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: ARG 57 - ASN 58 MODEL 3 OMEGA =229.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: ASN 58 - ARG 59 MODEL 3 OMEGA =329.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: SER 74 - LYS 75 MODEL 3 OMEGA =123.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: LYS 75 - GLU 76 MODEL 3 OMEGA =212.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: VAL 78 - ARG 79 MODEL 3 OMEGA =353.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: CIS PROLINE - PRO 2 MODEL 4
50: LYS 6 - PRO 7 MODEL 4 OMEGA =287.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: CYS 8 - PHE 9 MODEL 4 OMEGA = 7.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: CYS 11 - GLN 12 MODEL 4 OMEGA =228.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: SER 15 - SER 16 MODEL 4 OMEGA = 8.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: VAL 22 - SER 23 MODEL 4 OMEGA =142.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: THR 43 - CYS 44 MODEL 4 OMEGA = 2.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: CYS 44 - HIS 45 MODEL 4 OMEGA =351.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: HIS 45 - ARG 46 MODEL 4 OMEGA =140.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: CYS 50 - VAL 51 MODEL 4 OMEGA =210.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: ARG 57 - ASN 58 MODEL 4 OMEGA =356.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: SER 74 - LYS 75 MODEL 4 OMEGA =127.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: LYS 75 - GLU 76 MODEL 4 OMEGA =216.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: VAL 78 - ARG 79 MODEL 4 OMEGA =359.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: PRO 2 - ARG 3 MODEL 5 OMEGA =356.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: LYS 6 - PRO 7 MODEL 5 OMEGA =288.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: CYS 8 - PHE 9 MODEL 5 OMEGA = 6.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: CYS 11 - GLN 12 MODEL 5 OMEGA =330.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ILE 41 - TYR 42 MODEL 5 OMEGA = 0.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: THR 43 - CYS 44 MODEL 5 OMEGA =357.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: CYS 44 - HIS 45 MODEL 5 OMEGA =346.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: HIS 45 - ARG 46 MODEL 5 OMEGA = 47.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: VAL 51 - ILE 52 MODEL 5 OMEGA =224.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: ARG 57 - ASN 58 MODEL 5 OMEGA =354.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: SER 74 - LYS 75 MODEL 5 OMEGA =125.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: LYS 75 - GLU 76 MODEL 5 OMEGA =213.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: VAL 78 - ARG 79 MODEL 5 OMEGA =356.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: LYS 6 - PRO 7 MODEL 6 OMEGA =322.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: PRO 7 - CYS 8 MODEL 6 OMEGA =221.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: CYS 8 - PHE 9 MODEL 6 OMEGA = 6.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: CYS 11 - GLN 12 MODEL 6 OMEGA =331.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: ASP 13 - LYS 14 MODEL 6 OMEGA = 2.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: THR 43 - CYS 44 MODEL 6 OMEGA = 25.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: HIS 45 - ARG 46 MODEL 6 OMEGA = 80.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: CYS 50 - VAL 51 MODEL 6 OMEGA =123.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: VAL 51 - ILE 52 MODEL 6 OMEGA = 12.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: VAL 55 - THR 56 MODEL 6 OMEGA =234.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: ARG 57 - ASN 58 MODEL 6 OMEGA = 11.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: ARG 64 - LEU 65 MODEL 6 OMEGA =147.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: SER 74 - LYS 75 MODEL 6 OMEGA =120.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: LYS 75 - GLU 76 MODEL 6 OMEGA =211.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: VAL 78 - ARG 79 MODEL 6 OMEGA =351.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
91: LYS 6 - PRO 7 MODEL 7 OMEGA =320.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: PRO 7 - CYS 8 MODEL 7 OMEGA =218.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: CYS 8 - PHE 9 MODEL 7 OMEGA = 6.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: CYS 11 - GLN 12 MODEL 7 OMEGA =336.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: GLY 17 - TYR 18 MODEL 7 OMEGA = 10.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: MET 40 - ILE 41 MODEL 7 OMEGA =149.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: THR 43 - CYS 44 MODEL 7 OMEGA =354.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: CYS 44 - HIS 45 MODEL 7 OMEGA =352.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: HIS 45 - ARG 46 MODEL 7 OMEGA =131.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: CYS 50 - VAL 51 MODEL 7 OMEGA =307.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: VAL 51 - ILE 52 MODEL 7 OMEGA =222.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: ARG 57 - ASN 58 MODEL 7 OMEGA =357.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: SER 74 - LYS 75 MODEL 7 OMEGA =119.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: LYS 75 - GLU 76 MODEL 7 OMEGA =210.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: VAL 78 - ARG 79 MODEL 7 OMEGA = 4.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: CIS PROLINE - PRO 2 MODEL 8
107: LYS 6 - PRO 7 MODEL 8 OMEGA =316.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: PRO 7 - CYS 8 MODEL 8 OMEGA =222.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: CYS 8 - PHE 9 MODEL 8 OMEGA = 8.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: CYS 11 - GLN 12 MODEL 8 OMEGA =330.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: TYR 18 - HIS 19 MODEL 8 OMEGA =111.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: VAL 22 - SER 23 MODEL 8 OMEGA =136.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: CYS 44 - HIS 45 MODEL 8 OMEGA = 3.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: HIS 45 - ARG 46 MODEL 8 OMEGA = 30.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: CYS 50 - VAL 51 MODEL 8 OMEGA =220.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: ASN 58 - ARG 59 MODEL 8 OMEGA =340.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: ARG 64 - LEU 65 MODEL 8 OMEGA =147.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: SER 74 - LYS 75 MODEL 8 OMEGA =125.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: LYS 75 - GLU 76 MODEL 8 OMEGA =212.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: VAL 78 - ARG 79 MODEL 8 OMEGA =350.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: LYS 6 - PRO 7 MODEL 9 OMEGA =311.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: PRO 7 - CYS 8 MODEL 9 OMEGA =219.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: CYS 8 - PHE 9 MODEL 9 OMEGA = 5.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: CYS 11 - GLN 12 MODEL 9 OMEGA =331.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: GLY 17 - TYR 18 MODEL 9 OMEGA = 6.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: VAL 22 - SER 23 MODEL 9 OMEGA =126.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: CYS 44 - HIS 45 MODEL 9 OMEGA =135.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: HIS 45 - ARG 46 MODEL 9 OMEGA = 51.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: CYS 50 - VAL 51 MODEL 9 OMEGA =288.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: VAL 51 - ILE 52 MODEL 9 OMEGA =220.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: VAL 55 - THR 56 MODEL 9 OMEGA =211.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: ARG 57 - ASN 58 MODEL 9 OMEGA =359.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: ARG 64 - LEU 65 MODEL 9 OMEGA =147.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: SER 74 - LYS 75 MODEL 9 OMEGA =121.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: LYS 75 - GLU 76 MODEL 9 OMEGA =210.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: VAL 78 - ARG 79 MODEL 9 OMEGA =352.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: CIS PROLINE - PRO 2 MODEL 10
138: LYS 6 - PRO 7 MODEL 10 OMEGA =282.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
139: CYS 8 - PHE 9 MODEL 10 OMEGA = 6.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
140: CYS 11 - GLN 12 MODEL 10 OMEGA =229.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
141: GLY 17 - TYR 18 MODEL 10 OMEGA =346.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
142: THR 43 - CYS 44 MODEL 10 OMEGA = 3.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
143: CYS 44 - HIS 45 MODEL 10 OMEGA =346.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
144: HIS 45 - ARG 46 MODEL 10 OMEGA =134.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
145: CYS 50 - VAL 51 MODEL 10 OMEGA =213.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
146: ILE 52 - ASN 53 MODEL 10 OMEGA =148.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
147: VAL 55 - THR 56 MODEL 10 OMEGA =236.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
148: ARG 57 - ASN 58 MODEL 10 OMEGA = 7.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
149: SER 74 - LYS 75 MODEL 10 OMEGA =117.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
150: LYS 75 - GLU 76 MODEL 10 OMEGA =211.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
151: VAL 78 - ARG 79 MODEL 10 OMEGA =357.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
152: LYS 6 - PRO 7 MODEL 11 OMEGA = 35.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
153: CYS 8 - PHE 9 MODEL 11 OMEGA =359.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
154: CYS 11 - GLN 12 MODEL 11 OMEGA =231.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
155: GLY 17 - TYR 18 MODEL 11 OMEGA = 8.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
156: MET 40 - ILE 41 MODEL 11 OMEGA =123.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
157: TYR 42 - THR 43 MODEL 11 OMEGA =144.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
158: HIS 45 - ARG 46 MODEL 11 OMEGA =112.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
159: VAL 55 - THR 56 MODEL 11 OMEGA =237.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
160: THR 56 - ARG 57 MODEL 11 OMEGA =251.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
161: SER 74 - LYS 75 MODEL 11 OMEGA =118.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
162: LYS 75 - GLU 76 MODEL 11 OMEGA =211.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
163: VAL 78 - ARG 79 MODEL 11 OMEGA =353.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
164: LYS 6 - PRO 7 MODEL 12 OMEGA =289.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
165: CYS 8 - PHE 9 MODEL 12 OMEGA =358.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
166: CYS 11 - GLN 12 MODEL 12 OMEGA =355.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
167: SER 15 - SER 16 MODEL 12 OMEGA =105.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
168: GLY 17 - TYR 18 MODEL 12 OMEGA = 6.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
169: THR 43 - CYS 44 MODEL 12 OMEGA = 4.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
170: CYS 44 - HIS 45 MODEL 12 OMEGA =348.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
171: HIS 45 - ARG 46 MODEL 12 OMEGA =137.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
172: ASN 53 - LYS 54 MODEL 12 OMEGA =297.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
173: VAL 55 - THR 56 MODEL 12 OMEGA =227.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
174: ARG 57 - ASN 58 MODEL 12 OMEGA = 9.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
175: SER 74 - LYS 75 MODEL 12 OMEGA =116.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
176: LYS 75 - GLU 76 MODEL 12 OMEGA =213.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
177: VAL 78 - ARG 79 MODEL 12 OMEGA = 0.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
178: LYS 6 - PRO 7 MODEL 13 OMEGA =310.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
179: PRO 7 - CYS 8 MODEL 13 OMEGA =218.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
180: CYS 8 - PHE 9 MODEL 13 OMEGA = 5.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
181: CYS 11 - GLN 12 MODEL 13 OMEGA =230.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
182: GLY 17 - TYR 18 MODEL 13 OMEGA = 10.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
183: SER 35 - ILE 36 MODEL 13 OMEGA =149.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
184: ILE 41 - TYR 42 MODEL 13 OMEGA = 10.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
185: CYS 44 - HIS 45 MODEL 13 OMEGA =346.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
186: HIS 45 - ARG 46 MODEL 13 OMEGA =145.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
187: CYS 50 - VAL 51 MODEL 13 OMEGA =212.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
188: ILE 52 - ASN 53 MODEL 13 OMEGA =145.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
189: VAL 55 - THR 56 MODEL 13 OMEGA =225.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
190: ARG 57 - ASN 58 MODEL 13 OMEGA = 7.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
191: SER 74 - LYS 75 MODEL 13 OMEGA =118.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
192: LYS 75 - GLU 76 MODEL 13 OMEGA =212.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
193: VAL 78 - ARG 79 MODEL 13 OMEGA =352.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
194: CIS PROLINE - PRO 2 MODEL 14
195: LYS 6 - PRO 7 MODEL 14 OMEGA =310.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
196: PRO 7 - CYS 8 MODEL 14 OMEGA =216.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
197: CYS 8 - PHE 9 MODEL 14 OMEGA = 7.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
198: CYS 11 - GLN 12 MODEL 14 OMEGA =233.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
199: GLY 17 - TYR 18 MODEL 14 OMEGA = 11.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
200: MET 40 - ILE 41 MODEL 14 OMEGA =148.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
201: HIS 45 - ARG 46 MODEL 14 OMEGA = 56.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
202: CYS 50 - VAL 51 MODEL 14 OMEGA =136.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
203: VAL 55 - THR 56 MODEL 14 OMEGA =211.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
204: ARG 57 - ASN 58 MODEL 14 OMEGA =357.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
205: ARG 64 - LEU 65 MODEL 14 OMEGA =140.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
206: SER 74 - LYS 75 MODEL 14 OMEGA =118.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
207: LYS 75 - GLU 76 MODEL 14 OMEGA =210.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
208: VAL 78 - ARG 79 MODEL 14 OMEGA =357.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
209: LYS 6 - PRO 7 MODEL 15 OMEGA =272.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
210: CYS 8 - PHE 9 MODEL 15 OMEGA = 0.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
211: CYS 11 - GLN 12 MODEL 15 OMEGA = 5.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
212: GLY 17 - TYR 18 MODEL 15 OMEGA =346.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
213: THR 43 - CYS 44 MODEL 15 OMEGA = 2.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
214: CYS 44 - HIS 45 MODEL 15 OMEGA =351.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
215: HIS 45 - ARG 46 MODEL 15 OMEGA =133.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
216: ILE 52 - ASN 53 MODEL 15 OMEGA =148.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
217: VAL 55 - THR 56 MODEL 15 OMEGA =250.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
218: THR 56 - ARG 57 MODEL 15 OMEGA =148.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
219: ARG 57 - ASN 58 MODEL 15 OMEGA = 0.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
220: ARG 64 - LEU 65 MODEL 15 OMEGA =149.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
221: SER 74 - LYS 75 MODEL 15 OMEGA =120.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
222: LYS 75 - GLU 76 MODEL 15 OMEGA =213.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
223: VAL 78 - ARG 79 MODEL 15 OMEGA =356.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR ensembles
DataCriteria
Number of conformers (submitted / calculated)15 / -
Representative

-
Components

#1: Protein RETINOIC ACID RECEPTOR


Mass: 9434.069 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / References: UniProt: P10826
#2: Chemical ChemComp-ZN / ZINC ION


Mass: 65.409 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: Zn

-
Experimental details

-
Experiment

ExperimentMethod: SOLUTION NMR

-
Processing

NMR ensembleConformers submitted total number: 15

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbjlvh1.pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more